Table 1.
PIM-1 Staining in TMA
| Staining intensity | Staining extent | Median intensity | Median extent | ||
|---|---|---|---|---|---|
| MLPS (n = 5) | 3,3,3,3,3 | 1,1,2,2,3 | MLPS | 3 | 2 |
| CCS (n = 1) | 2 | 1 | All non-adipocytic tumours | 0.5 | 0.5 |
| DSRCT (n = 1) | 1 | 3 | |||
| RMS (n = 5) | 0,1,1,1,1 | 0,1,1,1,1 | |||
| EWS/PNET (n = 7) | 0,0,1,1,1,1,1 | 0,0,2,3,3,3,3 | |||
| SS (n = 4) | 0,0,0,0 | 0,0,0,0 | |||
| MCS (n = 3) | 1,1,1 | 1,1,1 | |||
| NB (n = 5) | 0,0,0,1,1 | 0,0,0,1,1 | |||
| DFSP (n = 4) | 0,0,0,0 | 0,0,0,0 | |||
| Mes CS (n = 1) | 0 | 0 | P-value | <0.05 | >0.05 |
MLPS, myxoid liposarcoma; CCS, clear cell sarcoma; DSRCT, desmoplastic round cell tumour; RMS, rhabdomyosarcoma; Sections show: synovial sarcoma; MCS, myxoid chondrosarcoma; EWS/PNET, Ewing sarcoma/Primitive neuroectodermal tumour; NB, neuroblastoma; DFSP, dermatofibrosarcoma protuberans; Mes CS, mesenchymal chondrosarcoma.